Management of atrial fibrillation

Timothy Watson; Gregory Lip

doi:10.1007/s00059-006-2932-5

Management of atrial fibrillation

Timothy Watson, Gregory Lip

Research output: Contribution to journal › Article

1 Citation (Scopus)

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting an estimated 4.5 million people within the European Union. Indeed, the prevalence of AF continues to rise, in view of the aging population and the better management of heart attacks, making it the new "epidemic". Irrespective of a rate control or rhythm control strategy, appropriate antithrombotic therapy is central to AF management, by reducing the risk of stroke and thromboembolism. This overview focuses on the management of AF, with reference to recently published guidelines and describes their application in clinical practice using three clinical case scenarios.

Original language	English
Pages (from-to)	849-56
Number of pages	8
Journal	Herz
Volume	31
Issue number	9
DOIs	https://doi.org/10.1007/s00059-006-2932-5
Publication status	Published - 1 Dec 2006

Access to Document

10.1007/s00059-006-2932-5

Cite this

@article{525f325a057142aaa00f57f554a90fd1,

title = "Management of atrial fibrillation",

abstract = "Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting an estimated 4.5 million people within the European Union. Indeed, the prevalence of AF continues to rise, in view of the aging population and the better management of heart attacks, making it the new {"}epidemic{"}. Irrespective of a rate control or rhythm control strategy, appropriate antithrombotic therapy is central to AF management, by reducing the risk of stroke and thromboembolism. This overview focuses on the management of AF, with reference to recently published guidelines and describes their application in clinical practice using three clinical case scenarios.",

author = "Timothy Watson and Gregory Lip",

year = "2006",

month = dec,

day = "1",

doi = "10.1007/s00059-006-2932-5",

language = "English",

volume = "31",

pages = "849--56",

journal = "Herz",

issn = "1615-6692",

publisher = "Springer",

number = "9",

}

TY - JOUR

T1 - Management of atrial fibrillation

AU - Watson, Timothy

AU - Lip, Gregory

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting an estimated 4.5 million people within the European Union. Indeed, the prevalence of AF continues to rise, in view of the aging population and the better management of heart attacks, making it the new "epidemic". Irrespective of a rate control or rhythm control strategy, appropriate antithrombotic therapy is central to AF management, by reducing the risk of stroke and thromboembolism. This overview focuses on the management of AF, with reference to recently published guidelines and describes their application in clinical practice using three clinical case scenarios.

AB - Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting an estimated 4.5 million people within the European Union. Indeed, the prevalence of AF continues to rise, in view of the aging population and the better management of heart attacks, making it the new "epidemic". Irrespective of a rate control or rhythm control strategy, appropriate antithrombotic therapy is central to AF management, by reducing the risk of stroke and thromboembolism. This overview focuses on the management of AF, with reference to recently published guidelines and describes their application in clinical practice using three clinical case scenarios.

U2 - 10.1007/s00059-006-2932-5

DO - 10.1007/s00059-006-2932-5

M3 - Article

C2 - 17180647

SN - 1615-6692

VL - 31

SP - 849

EP - 856

JO - Herz

JF - Herz

IS - 9

ER -

Management of atrial fibrillation

Abstract

Access to Document

Fingerprint

Cite this